AI Article Synopsis

  • Obscure gastrointestinal bleeding can occur when the source of bleeding is unknown, even after procedures like balloon-assisted endoscopy; Dieulafoy's lesion in the small bowel is often suspected as the cause.
  • A retrospective study analyzed 38 patients diagnosed with Dieulafoy's lesion through double-balloon endoscopy, focusing on their clinical characteristics and whether bleeding could be predicted before the procedure.
  • The median age of patients was 72, with a high comorbidity rate; most lesions were found in the upper jejunum and lower ileum, with a 21% rebleeding rate after endoscopic treatment, and multiple episodes of hematochezia linked to the likelihood of receiving multiple diagnoses.

Article Abstract

Background: Obscure gastrointestinal bleeding refers to bleeding for which the source cannot be ascertained even through balloon-assisted endoscopy. In certain instances, Dieulafoy's lesion in the small bowel is presumed to be the underlying cause.

Aim: This retrospective study aimed to elucidate the clinical characteristics of Dieulafoy's lesion in the small bowel as diagnosed via double-balloon endoscopy while also exploring the feasibility of predicting bleeding from Dieulafoy's lesion prior to endoscopy in cases of obscure gastrointestinal bleeding.

Methods: A comprehensive analysis of our database was conducted, identifying 38 patients who received a diagnosis of Dieulafoy's lesion and subsequently underwent treatment via double-balloon endoscopy. The clinical background, diagnosis, and treatment details of patients with Dieulafoy's lesion were carefully examined.

Results: The median age of the 38 patients was 72 years, and 50% of the patients were male. A total of 26 (68%) patients exhibited a high comorbidity index. The upper jejunum and lower ileum were the most frequently reported locations for the occurrence of Dieulafoy's lesion in the small bowel. The detected Dieulafoy's lesions exhibited active bleeding (n = 33) and an exposed vessel with plaque on the surface (n = 5). Rebleeding after endoscopic treatment occurred in 8 patients (21%, median period: 7 days, range: 1-366 days). We conducted an analysis to determine the definitive nature of the initial double-balloon endoscopy diagnosis. Multivariate analysis revealed that hematochezia of ≥ 2 episodes constituted the independent factor associated with ≥ 2 double-balloon endoscopy diagnoses. Additionally, we explored factors associated with rebleeding following endoscopic treatment. Although the number of hemoclips utilized displayed a likely association, multivariate analysis did not identify any independent factor associated with rebleeding.

Conclusion: If a patient encounters multiple instances of hematochezia, promptly scheduling balloon-assisted endoscopy, equipped with optional instruments without delay is advised, after standard endoscopic evaluation with esophagogastroduodenoscopy and colonoscopy is unrevealing.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464443PMC
http://dx.doi.org/10.1186/s12876-023-02913-1DOI Listing

Publication Analysis

Top Keywords

dieulafoy's lesion
28
double-balloon endoscopy
20
lesion small
16
small bowel
16
clinical characteristics
8
dieulafoy's
8
characteristics dieulafoy's
8
bowel diagnosed
8
endoscopy
8
obscure gastrointestinal
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!